Abdul Salim Sohail, Thomas Litty, Quorles Amanda, Hamrahian Seyed Mehrdad, Fülöp Tibor
Division of Nephrology, Department of Internal Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Department of Radiation Oncology & Biomolecular Sciences, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Hemodial Int. 2018 Apr;22(2):E26-E32. doi: 10.1111/hdi.12626. Epub 2017 Dec 11.
The occurrence of the autoimmune blistering disease, bullous pemphigoid (BP), in patients with failed renal allograft is rare and the few reported cases suggest various provocative factors without reaching a consensus. Here we report the case of a patient presenting with bullous lesions soon after the complete discontinuation of immunosuppressant therapy following renal allograft failure. Skin biopsy confirmed the diagnosis of BP. Administration of systemic corticosteroid controlled the occurrence of BP lesions in our patient. Increased clinical suspicion is warranted in cases of patients with renal transplant failure, since withdrawal of the immunosuppressant therapy could lead to unmasking the underlying autoimmune skin disease.
在肾移植失败的患者中,自身免疫性水疱病大疱性类天疱疮(BP)的发生较为罕见,少数已报道的病例提示了各种诱发因素,但尚未达成共识。在此,我们报告一例肾移植失败后完全停用免疫抑制治疗后不久出现水疱性皮损的患者。皮肤活检确诊为BP。全身性糖皮质激素治疗控制了该患者BP皮损的发生。对于肾移植失败的患者,临床应提高警惕,因为停用免疫抑制治疗可能会使潜在的自身免疫性皮肤病显现出来。